cardiovascular disease
Conditions
Interventions
R group:20 minutes before TEE examination, patients in group R received a loading dose of 0.1 mg/kg of remdesilam, which was pumped out within 10 minutes. Subsequently, continuous intravenous infusion
D group:20 minutes before TEE examination, the loading dose of dexmedetomidine (0.5 µ g/kg) in group D was pumped for 10 minutes, and the Dex maintenance dose was 0.4 µ g/kg/h until the end of the ope
Sponsors
Shifang people's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Male or female, aged 18 to 80, American Society of Anesthesiologists ASA grades I to III.
Exclusion criteria
Exclusion criteria: Including patients with severe heart disease (complex congenital heart disease, heart failure, and severe arrhythmia), pulmonary dysfunction, or any other disease that may hinder outpatient TEE surgery; Any patient with oral to gastric pathological conditions that may hinder TEE insertion and transmission; Body mass index>30; Pregnant; Hemorrhagic diseases; Drug abuse or frequent use of painkillers; And patients who are allergic to research drugs. In addition, patients who are unable to communicate and those who refuse to provide informed consent are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ramsay score;VAS score;Patient satisfaction rating;Steward's sobriety rating; | — |
Secondary
| Measure | Time frame |
|---|---|
| Doctor's satisfaction rating for anesthesia;Perioperative complications; | — |
Countries
China
Contacts
Public ContactLin Zeng
Shifang People's Hospital
Outcome results
None listed